In the ACHIEVE-1 study, a 36 mg dose resulted in a reduction in HbA1c of 1.31.6% from a baseline of 8.0%, and an average weight loss of 7.9% (approximately 16.0 lbs) over 40 weeks
Similarly, the STZ injection resulted in a spike of HbA1C (Figure 3c, red, blue, and green curves) compared to the sham group (Figure 3c, black curve)
Appetite Changes : Many users report a decrease in appetite, which can aid in weight loss
So it takes at least 31 days before it starts to be effective
Personalized medicine with compounded semaglutide means tailored dosing
Serious adverse effects are uncommon when dosing is appropriate and therapy is supervised, but ongoing monitoring and periodic labs are recommended to watch for shifts in glucose, fluid balance, or hormone sensitivity